The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites

International Journal of Oncology

Volumn 29, Issue 1, 2006, Pages 139-145

  Deichmann, Martin ^a   Krahl, Dieter ^b   Thome, Marianne ^a   Wüst, Kirsten ^c   Hassanzadeh, Judith ^a   Helmke, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Institute for Dermatohistology   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

B raf; Melanoma; Oncogene; Polymerase chain reaction; Single strand conformation polymorphism; UV exposure

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ARTICLE; ENVIRONMENTAL EXPOSURE; GENETICS; HUMAN; MELANOMA; MUTATION; PATHOLOGY; RADIATION INJURY; RISK FACTOR; SKIN TUMOR; TIME; ULTRAVIOLET RADIATION;

ENVIRONMENTAL EXPOSURE; HUMANS; MELANOMA; MUTATION; NEOPLASMS, RADIATION-INDUCED; PROTO-ONCOGENE PROTEINS B-RAF; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 34250347021     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.1.139     Document Type: Article

References (37)

1. Rigel DS, Friedman RJ and Kopf AW: The incidence of malignant melanoma in the United States, issues as we approach the 21st century. J Am Acad Dermatol 34: 839-847, 1996.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davies N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
3. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM and Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 33: 19-20, 2003.
4. Deichmann M, Thome M, Benner A and Näher H: B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome. Oncology 66: 411-419, 2004.
5. Omholt K, Platz A, Kanter L, Ringborg U and Hansson J: NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 9: 6483-6488, 2003.
6. Gilchrest BA, Eller MS, Geller AC and Yaar M: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340: 1341-1348, 1999.
7. Hemminki K, Lonnstedt I, Vaittinen P and Lichtenstein P: Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet Epidemiol 20: 107-116, 2001.
8. Polsky D, Cordon-Cardo C and Houghton A: Molecular biology of melanoma. In: The Molecular Basis of Cancer, 2nd edition. Liotta LA (ed). Saunders, Philadelphia, pp385-404, 2001.
9. Koh HK, Kligler BE and Lew RA: Sunlight and cutaneous malignant melanoma, evidence for and against causation. Photochem Photobiol 51: 765-779, 1990.
10. Elwood JM and Jopson J: Melanoma and sun exposure, an overview of published studies. Int J Cancer 73: 198-203, 1997.
11. Gallagher RP, Elwood JM and Yang CP: Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 44: 813-815, 1989.
12. Walter SD, King WD and Marrett LD: Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation, results of a case-control study in Ontario, Canada. Int J Epidemiol 28: 48-427, 1999.
13. Vollmer RT and Seigler HF: Using a continous transformation of the Breslow thickness for prognosis in cutaneous melanoma. Am J Clin Pathol 105: 205-212, 2001.
14. Kumar R, Angelini S and Hemminki K: Activating BRAF and N-RAS mutations in sporadic primary melanomas, an inverse association with allelic loss on chromosome 9. Oncogene 22: 9217-9224, 2003.
15. Daya-Grosjean L, Dumaz N and Sarasin A: The specificity of p53 mutation spectra in sunlight induced human cancers. J Photochem Photobiol 28: 115-124, 1995.
16. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene, clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
17. Moles UP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C and Basset-Seguin N: p53 gene mutations in human epithelial skin cancers. Oncogene 8: 583-588, 1993.
18. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE and Brash DE: Mutation hotspots due to sunlight in the p53 gene of non-melanoma skin cancers. Proc Natl Acad Sci USA 90: 4216-4220, 1993.
19. Jhappan C, Noonan FP and Merlino G: Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22: 3099-3112, 2003.
20. Elwood JM, Gallagher RP, Hill GB and Pearson JCG: Cutaneous melanoma in relation to intermittent and constant sun exposure, the Western Canada Melanoma Study. Int J Cancer 35: 427-433, 1985.
21. Holman CD, Armstrong BK and Heenan PJ: Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 76: 403-414, 1986.
22. Elwood JM, Gallagher RP, Worth AJ, Wood WS and Pearson JCG: Etiological differences between subtypes of cutaneous malignant melanoma, Western Canada Melanoma Study. J Natl Cancer Inst 78: 37-44, 1987.
23. Dong J, Phelbs RG, Qiao R, Yao S, Benard O, Ronai Z and Aaronson SA: BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 63: 3883-3885, 2003.
24. Peyssonnaux C and Eychène A: The Raf/MEK/ERK pathway, new concepts of activation. Biol Cell 93: 53-62, 2001.
25. Van Elsas A, Zerp SF, van der Flier S, Kruse KM, Aarnoudse C, Hayward NK, Ruiter DJ and Schrier PI: Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 149: 739-744, 1996.
26. Jiveskog S, Ragnarsson-Olding B, Platz A and Ringborg U: N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 111: 757-761, 1998.
27. Vn't Veer LJ, Burgering BMT, Versteeg R, Boot AJM, Ruiter DJ, Osanto S, Schrier PI and Bos JL: N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 9: 3114-3116, 1989.
28. Wagner SN, Ockenfels HM, Wagner C, Hofler H and Goos M: Ras gene mutations, a rare event in non-metastatic primary malignant melanoma. J Invest Dermatol 104: 868-871, 1995.
29. Kraehn GM, Schartl M and Peter RU: Human malignant melanoma, a genetic disease? Cancer 75: 1228-1237, 1995.
30. Halaban R: The regulation of normal melanocyte proliferation. Pigment Cell Res 13: 4-14, 2000.
31. Busca R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychène A, Ortonne JP and Ballotti R: Ras mediates the cDMAP-dependent activation of extracellular signal-related kinases (ERKs) in melanocytes. EMBO J 19: 2900-2910, 2000.
32. Englaro W, Rezzonico R, Durand-Clément M, Lallemand D, Ortonne JP and Ballotti R: Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 270: 24315-24320, 1995.
33. Imokawa G, Yada Y and Miyagishi M: Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 267: 24675-24680, 1992.
34. Yada Y, Higuchi K and Imokawa G: Effects of endothelins on signal transduction and proliferation in human melanocytes. J Biol Chem 266: 18352-18357, 1991.
35. Imokawa G, Yada Y and Kimura M: Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J 314: 305-312, 1996.
36. Swope VB, Medrano EE, Smalara D and Abdel-Malek ZA: Long-term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp Cell Res 217: 453-459, 1995.
37. Imokawa G, Kobayasi T and Miyagishi M: Intracellular signaling mechanisms leading to synergistic effects of endothelin-1 and stem cell factor on proliferation of cultured human melanocytes, cross-talk via trans-activation of the tyrosine kinase c-kit receptor. J Biol Chem 275: 33321-33328, 2000.